CareLit Fachartikel

Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

S. Petri, M. Kiaei, M. Damiano, A. Hiller, E. Wille, G. Manfredi, N.Y. Calingasan, H.H. Szeto, M.F. Beal · Aktuelle Neurologie · 2006 · Heft 09

Dokument
1165422
CareLit-ID
Jahr
2006
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Neurologie
Autor:innen
S. Petri, M. Kiaei, M. Damiano, A. Hiller, E. Wille, G. Manfredi, N.Y. Calingasan, H.H. Szeto, M.F. Beal
Ausgabe
Heft 09 / 2006
Seiten
–
Erschienen: 2006-09-27 00:00:00
ISSN
0302-4350

Zusammenfassung

Introduction: Reactive oxygen species (ROS) play a major role in the pathogenesis of neurodegenerative diseases. They are important contributors to necrotic and apoptotic cell death. Structural and functional abnormalities of mitochondria resulting in the generation of ROS, aggregate formation and the release of proapoptotic factors are implicated in ALS pathogenesis. Results: In the present study we investigated a novel peptide antioxidant (SS-31) targeted to the inner mitochondrial membrane for its therapeutic effects both in vitro and in vivo in the G93A mouse model of Amyotrophic Lateral Sclerosis (ALS). SS-…

Schlagworte

Amyotrophic Lateral Sclerosis Reactive Oxygen Species Antioxidants Aktuelle Neurologie